Verdict No. 3013 · Search date 2026-09-07 · Methodology v0.9
Oral sucrose solution administered by a clinician two minutes before vaccination,
does it really help with Reduced behavioral pain and crying after infant vaccination?
30-Second Summary
C
Evidence Grade C · 54 · Safety caution
Behavioral vaccination-pain signals for oral sucrose must not absorb pacifier, water, or breastfeeding effects
The studies involved a clinician giving a small amount at a specified concentration immediately before vaccination. Do not improvise concentrated sugar water or use it repeatedly for routine soothing; infants at aspiration risk require clinical judgment. When feasible, breastfeeding during vaccination has more direct comparative support.
What the
research showsGrade C with 54 points. In a 100-infant randomized trial, 24% sucrose plus a pacifier reduced behavioral pain at 5, 7, and 9 minutes versus sterile water, but only 38 versus 45 were analyzed. A 285-infant trial found no sucrose-specific advantage over water, and a separate 120-infant trial found breastfeeding superior to sucrose.
research showsGrade C with 54 points. In a 100-infant randomized trial, 24% sucrose plus a pacifier reduced behavioral pain at 5, 7, and 9 minutes versus sterile water, but only 38 versus 45 were analyzed. A 285-infant trial found no sucrose-specific advantage over water, and a separate 120-infant trial found breastfeeding superior to sucrose.
What the
ads claimThe claim that sugar water eliminates vaccine pain converts a behavioral-score signal into blocked nociception and attributes breastfeeding or sucking effects to sucrose.
ads claimThe claim that sugar water eliminates vaccine pain converts a behavioral-score signal into blocked nociception and attributes breastfeeding or sucking effects to sucrose.
Useful facts when choosing a product
- The key positive trial combined 24% sucrose with a pacifier.
- A 285-infant study found no sucrose-specific advantage over water.
- Breastfeeding was superior to sucrose in a separate trial.
Gap Measurement · Verdict 3013 · C 54
What the research actually shows
Clinicians administered small doses of 12% or 24% sucrose about two minutes before vaccination and compared them with water, no treatment, or breastfeeding. Pain-specific EEG and spinal reflexes during neonatal heel lance were kept separate.
Why this is classified as C (54)
Patient-centered behavioral pain and independent studies are strengths, but composite attribution, 17 excluded participants, concentration and age discordance, and a null objective nociception primary outcome give C with 54 points.
Counterpoint. Less visible pain behavior is not identical to less neural nociception; the heel-lance EEG primary outcome was null.
Rejudgment record. Cross-check applied — Separated sucrose versus water from sucrose-plus-pacifier and breastfeeding, and did not pool vaccination behavior with heel-lance EEG
Scoring profile behind this grade
| Endpoint | P | Patient-reported treatment goal - the symptom is the goal |
| Replication | R1 | Single confirmatory trial |
| Independence | I2 | Decisive evidence is publicly or non-profit funded |
| Effect size | E+ | Meets the clinically important threshold |
| Precision | C0 | The confidence interval leaves room for benefit |
The scoring table and the verdict agree (C).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Reduced behavioral pain and crying after vaccination | C | A positive composite trial is offset by inconsistent concentration and age findings in a larger water comparison. |
| Reduced pain-specific neural response | D | The prespecified EEG primary endpoint was null in a separate heel-lance trial. |
Cross-check — AI research and Codex final gate
AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Study 1 | Randomized sucrose-plus-pacifier versus sterile-water trial | 45 | Indexed as non-U.S. government support; no manufacturer involvement | Behavioral pain scores at 5, 7, and 9 minutes | Lower with the sucrose composite at each time; mean 3.8 versus 4.8 at seven minutes | Key positive vaccination trial |
| Study 2 | Double-blind randomized sucrose, water, and no-intervention trial | 285 | Specific funding and conflicts unverified | Pain-induced vocalization during vaccination | At two weeks both sucrose and water reduced crying versus no intervention; no sucrose-specific effect | Larger direct contrary evidence |
| Study 3 | Three-arm randomized sucrose, breastfeeding, and control trial | 120 | Specific funding and conflicts unverified | FLACC pain, crying time, and heart rate | Breastfeeding superior to sucrose and control, P<.001 | Active-control relative effect |
Receipt — 4 References
All 4 cited sources were verified for existence at the original page (as of 2026-09-07).
Hatfield LA, Gusic ME, Dyer AM, Polomano RC. Analgesic properties of oral sucrose during routine immunizations at 2 and 4 months of age. Pediatrics. 2008;121:e327-e334. PMID: 18245406. DOI: 10.1542/peds.2006-3719. NCT00150189.
checkedAllen KD, White DD, Walburn JN. Sucrose as an analgesic agent for infants during immunization injections. Arch Pediatr Adolesc Med. 1996;150:270-274. PMID: 8603220. DOI: 10.1001/archpedi.1996.02170280040007.
checkedGad RF, Dowling DA, Abusaad FE, Bassiouny MR, Abd El Aziz MA. Oral Sucrose Versus Breastfeeding in Managing Infants' Immunization-Related Pain: A Randomized Controlled Trial. MCN Am J Matern Child Nurs. 2019;44:108-114. PMID: 30807328. DOI: 10.1097/NMC.0000000000000512.
checkedSlater R, Cornelissen L, Fabrizi L, et al. Oral sucrose as an analgesic drug for procedural pain in newborn infants: a randomised controlled trial. Lancet. 2010;376:1225-1232. PMID: 20817247. DOI: 10.1016/S0140-6736(10)61303-7. ISRCTN78390996.
checkedResearch and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Verification cutoff: 2026-09-07 · Corrections: none
Final verification and publication gate: Codex · Verification cutoff: 2026-09-07 · Corrections: none
Cite this verdict
[Chamgap] Oral Sucrose for Infant Vaccination Pain—Behavioral Calming Must Be Separated From Water, Pacifier, and Breastfeeding Effects — Evidence Grade C·54. 4 cited sources checked. Source: https://chamgap.com/en/verdicts/immunity/oral-sucrose-infant-vaccination-pain-crying/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.